You are here: Industry Insights > Pfizer

News List

GSK, Pfizer go for radical makeovers with giant consumer combo destined for spinoff fiercepharma
December 20, 2018
Turns out, after GlaxoSmithKline walked away from a chance to scoop up Pfizer’s consumer health business in March, it got another opportunity to team up on a deal.
GSK and Pfizer to create consumer healthcare JV pharmatimes
December 20, 2018
GlaxoSmithKline and Pfizer have unveiled plans to combine their consumer health businesses into a new world-leading Joint Venture worth around £9.8 billion.
GSK and Pfizer to create $13bn consumer healthcare joint venture pharmaceutical-technology
December 20, 2018
GlaxoSmithKline (GSK) and Pfizer have agreed to merge their consumer health businesses to create a new joint venture with an estimated £9.8bn ($12.7bn) in annual sales.....
Pfizer and Novartis collaborate to find liver disease therapy pharmaphorum
December 19, 2018
Pfizer has joined forces with Novartis to bring together the therapies they have been working on independently, to treat non-alcoholic steatohepatitis (NASH).....
Kineta Enters Research Collaboration and License Agreement with Pfizer americanpharmaceuticalreview
December 18, 2018
Kineta Immuno-Oncology has entered into a strategic research collaboration with Pfizer to develop RIG-I agonist immunotherapies for the treatment of cancer.....
Pfizer’s cut-price version of Avastin wins EU panel greenlight expressbpd
December 18, 2018
Pfizer’s Zirabev is a cheaper version to Roche Holding’s leading cancer drug Avastin
Pfizer receives positive CHMP opinion for oncology biosimilar, ZIRABEV™ (bevacizumab) worldpharmanews
December 17, 2018
Pfizer announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing authorization for ZIRABEV™ (bevacizumab).
Pfizer Initiates for 20-Valent Pneumococcal Conjugate Vaccine Phase 3 Program americanpharmaceuticalreview
December 17, 2018
Pfizer announced the initiation of a Phase 3 program for its 20-Valent pneumococcal conjugate vaccine (20vPnC) candidate, PF-06482077, for the prevention of invasive disease and .....
Pfizer still unable to get on top of problems at Hospira injectables plant fiercepharma
December 14, 2018
Since Pfizer’s Kansas plant received an FDA warning letter last year, the company has insisted it is making good progress on turning things around at the essential but troubled injectables facility.
FDA green lights Pfizer’s Lorbrena for aggressive lung cancer pharmaphorum
December 12, 2018
Pfizer’s drug Lorbrena (lorlatinib) can be used to treat certain types of advanced lung cancer.The US Food and Drug Administration (FDA) approved the treatment.....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page